Nath Bio-Genes (India) has informed that the Company had organized a conference call with the Investors/Analysts on Tuesday 17th October, 2023, post declaration of its Unaudited financial results for the quarter and half year ended 30th September 2023. A copy of transcript of conference call held with Investors/Analysts is enclosed and the same being uploaded on Company’s website.
The above information is a part of company’s filings submitted to BSE.